Sep 20, 2018 Practice Matters: The CGRP Inhibitors for Migraine Are Reaching the Market Why Not All ... Practice Matters: The CGRP Inhibitors for Migraine Are Reaching the Market Why Not All …And while not all neurologists embrace their merits, headache specialists who spoke to Neurology Today expressed concerns about the hoops they ... read morePublished on 2018-09-20